Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Biology, Malaria, Plasmodium vivax, Virology, Mycobacterium tuberculosis, and Plasmodium falciparum.
Anti-plasmid defense in hypervirulent <i>Klebsiella pneumoniae</i> involves Type I-like and Type IV restriction modification systems
Differential mucosal tropism and dissemination of classical and hypervirulent Klebsiella pneumoniae infection
Detection of florfenicol resistance in opportunistic Acinetobacter spp. infections in rural Thailand
An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis
Improving in vitro continuous cultivation of Plasmodium cynomolgi, a model for P. vivax
Integrative Genetic Manipulation of <i>Plasmodium cynomolgi</i> Reveals Multidrug Resistance-1 Y976F Associated With Increased In Vitro Susceptibility to Mefloquine
inPhocus: Current State and Challenges of Phage Research in Singapore
Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro
Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein
The Plasmodium liver-specific protein 2 (LISP2) is an early marker of liver stage development
Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages
Hepatic spheroids used as an in vitro model to study malaria relapse
Quantitative Proteomic Analysis of Simian Primary Hepatocytes Reveals Candidate Molecular Markers for Permissiveness to Relapsing Malaria <i>Plasmodium cynomolgi</i>
The addition of avibactam renders piperacillin an effective treatment for Mycobacterium abscessus infection in an in vivo model
UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes
Mutations in the Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug Resistance
Mutations in Genes for the F <sub>420</sub> Biosynthetic Pathway and a Nitroreductase Enzyme Are the Primary Resistance Determinants in Spontaneous <i>In Vitro</i> -Selected PA-824-Resistant Mutants of Mycobacterium tuberculosis
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis